6-(Thiophen-3-yl)purine-beta-D-(3’-deoxy-3’-fluoro)riboside

Modify Date: 2024-04-04 15:48:32

6-(Thiophen-3-yl)purine-beta-D-(3’-deoxy-3’-fluoro)riboside Structure
6-(Thiophen-3-yl)purine-beta-D-(3’-deoxy-3’-fluoro)riboside structure
Common Name 6-(Thiophen-3-yl)purine-beta-D-(3’-deoxy-3’-fluoro)riboside
CAS Number 1612191-90-8 Molecular Weight N/A
Density N/A Boiling Point N/A
Molecular Formula N/A Melting Point N/A
MSDS N/A Flash Point N/A

 Use of 6-(Thiophen-3-yl)purine-beta-D-(3’-deoxy-3’-fluoro)riboside


6-(Thiophen-3-yl)purine-beta-D-(3’-deoxy-3’-fluoro)riboside is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].

 Names

Name 9-(3-Deoxy-3-fluoro-β-D-ribofuranosyl)-6-(thiophen-3-yl)purine

  Biological Activity

Description 6-(Thiophen-3-yl)purine-beta-D-(3’-deoxy-3’-fluoro)riboside is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].
Related Catalog
References

[1]. Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88.  

 Chemical & Physical Properties

No Any Chemical & Physical Properties